872002-31-8

Upstream product

• 110-52-1 1,4-dibromo-butane 
• 58415-63-7 4-(5-octylpyrimidin-2-yl)phenol 
• 7779-41-1 1,1-dimethoxy decane 
• 439866-89-4 2-(methoxymethylene)decanal 
• 767-00-0 4-cyanophenol 
• 38148-63-9 p-amidinophenol hydrochloride 

Downstream Products

• 872002-32-9 ethyl 3,4-bis{4-[4-(5-octylpyrimidin-2-yl)phenyloxy]butyloxy}benzoate 
• 1403575-12-1 3-methyl-1-{4-[4-(5-octylpyrimidin-2-yl)phenoxy]butyl}imidazolium bromide 
• 1403575-34-7 1-{4-[4-(5-octylpyrimidin-2-yl)phenoxy]butyl}-3-[4-(dodecyloxy)phenyl]imidazolium bromide 
• 1403575-18-7 3-butyl-1-{4-[4-(5-octylpyrimidin-2-yl)phenoxy]butyl}imidazolium bromide 
• 1403575-28-9 3-dodecyl-1-{4-[4-(5-octylpyrimidin-2-yl)phenoxy]butyl}imidazolium bromide 
• 872002-33-0 3,4-bis{4-[4-(5-octylpyrimidin-2-yl)phenyloxy]butyloxy}benzoic acid 

Relevant academic research and scientific papers

Towards room temperature ionic liquid crystals: Linear versus bent imidazolium phenylpyrimidines

The synthesis and the mesomorphic properties of novel imidazolium salts with mesogenic 2-phenylpyrimidine or 2-alkylpyrimidinecarboxylic acid central cores are reported. The mesogenic units are connected to the imidazolium head groups via an alkoxy spacer

Influence of the alkyl spacer length on the phase transition behaviour of the Λ-shaped liquid crystal

We reported that a novel λ-shaped liquid-crystalline molecule 1-6 in which a cyanobiphenyl and two phenylpyrimidine groups are connected to 3, 4-dihydroxy-benzoic acid exhibits an incommensurate SmA phase. In the present study, we have prepared the homolo